CASE REPORT
Kasabach-Merritt syndrome in an infant with cavernous haemangioma
More details
Hide details
1
Department of Paediatrics #2, Ivan Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
Submission date: 2019-12-06
Final revision date: 2020-01-23
Acceptance date: 2020-01-24
Publication date: 2020-03-31
Pediatr Pol 2020;95(1):48-51
KEYWORDS
TOPICS
ABSTRACT
Kasabach-Merritt syndrome (KMS) is a potentially life-threatening consumptive coagulopathy associated with vascular malformations, whereas haemangiomas typically present in infancy, with rapid growth, thoracic location, and complicated clinical course demanding chemotherapy and radiotherapy have rarely been reported. We describe a case of a female infant with cavernous haemangioma of the right chest wall spreading to the pleural space and diaphragm, and complicated by KMS. Our patient presented an inadequate response to treatment with systemic corticosteroids, propranolol, and vincristine. Partial tumour regression and diminish of trapping of platelets in the tumour were achieved after radiotherapy only. The purpose of this report is to increase awareness about KMS, to illustrate the treatment challenges and to provide a basis for clinical decision-making in this rare, life-threatening condition.
REFERENCES (25)
1.
Osifo OD, Evbuomwan I. Hemangiomas in Children: Challenges and Outcome of Surgical Management in Benin City, Nigeria. Iran J Pediatr 2011; 21: 350-356.
2.
Schmid I, Klenk AK, Sparber-Sauer M, et al. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options. World J Pediatr 2018; 14: 322-329.
3.
Evagelidou E, Tsanou E, Asproudis I, et al. Orbital cavernous hemangioma in an infant with intracranial lesions: a case report. Cases J 2009; 2: 6912.
4.
Kaneko K, Kanai R. Cavernous hemangioma of the accessory parotid gland. J Craniofac Surg 2011; 22: e28-29.
5.
Wierzbicki JM, Henderson JH, Scarborough MT, et al. Intramuscular hemangiomas. Sports Health 2013; 5: 448-454.
6.
Hatley RM, Sabio H, Howell CG, et al. Successful management of an infant with a giant hemangioma of the retroperitoneum and Kasabach-Merritt syndrome with alpha-interferon. J Pediatr Surg 1993; 28: 1356-1357.
7.
Szlachetka DM. Kasabach-Merritt syndrome: a case review. Neonatal Netw 1998; 17: 7-15.
8.
Yadav D, Maheshwari A, Aneja S, et al. Neonatal Kasabach-Merritt phenomenon. Indian J Med Paediatr Oncol 2011; 32: 238-241.
9.
Master S, Kallam D, El-Osta H, Peddi P. Clinical Review: Management of Adult Kasabach-Merritt Syndrome Associated with Hemangiomas. J Blood Disord Transfus 2017; 8: 397.
10.
Kim JA, Choi YB, Yi ES, et al. Excellent outcome of medical treatment for Kasabach-Merritt syndrome: a single-center experience. Blood Res 2016; 51: 256-260.
11.
Ettlinger JJ, Fleming PJ, Joffe HS, Kennedy CT. Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon. J R Soc Med 1996; 89: 55-56.
12.
Hall DG. Kasabach-Merritt syndrome: Pathogenesis and management. Br J Hematol 2001; 112: 851-862.
13.
Phillips WG, Marsden JR. Kasabach-Merritt syndrome exacerbated by platelet transfusion. J R Soc Med 1993; 86: 231-232.
14.
Wang Z, Li K. Treatment of Kasabach-Merritt phenomenon. J Pediatr 2016; 170: 345.
15.
Fawcett SL, Grant I, Hall PN, et al. Vincristine as a treatment for a large haemangioma threatening vital functions. J Plast Reconstr Aesthet Surg 2004; 57: 168-171.
16.
Cichy B. Skuteczność propranololu w leczeniu naczyniaka niemowlęcego i naczyniakowatości limfatycznej. Pediatr Pol 2011; 86: 372-375.
17.
Rodriguez V, Lee A, Witman PM, Anderson PA. Kasabach-Merritt phenomenon: case series and retrospective review of the mayo clinic experience. J Pediatr Hematol Oncol 2009; 31: 522-526.
18.
Tang LY, Hing JW, Tang JY, et al. Predicting complications with pretreatment testing in infantile haemangioma treated with oral propranolol. Br J Ophthalmol 2016; 100: 902-906.
19.
Zhang L, Wu HW, Yuan W, Zheng JW. Propranolol therapy for infantile hemangioma: our experience. Drug Des Devel Ther 2017; 11: 1401-1408.
20.
Oksiuta M, Matuszczak E, Dębek W, et al. Successful exclusive propranolol therapy in an infant with life-threatening Kasabach-Merritt syndrome. J Pediatr Surg Case Rep 2013; 1: 200-202.
21.
Harrison P, Nguyen BA, Pickrell BB, Wright TS. Beta-Blockers as Therapy for Infantile Hemangiomas. Semin Plast Surg 2014; 28: 87-90.
22.
Zheng JW, Zhang L, Zhou Q, et al. A practical guide to the treatment of infantile hemangiomas of the head and neck. Int J Clin Exp Med 2013; 6: 851-860.
23.
Schild SE, Buskirk SJ, Frick LM, Cupps RE. Radiotherapy for large symptomatic hemangiomas. Int J Radiat Oncol Biol Phys 1991; 21: 729-735.
24.
Vakilha M, Farhan F, Samiei F, Shariat S. Intramuscular hemangioma of the forearm; Report of a case Iran. J Radiat Res 2003; 1: 175-179.
25.
Ogino I, Torikai K, Kobayasi S, et al. Radiation therapy for life- or function-threatening infant hemangioma. Radiology 2001; 218: 834-839.